US 11013767
Materials and methods for engineering cells and uses thereof in immuno-oncology
granted A61KA61K2239/31A61K2239/38
Quick answer
US patent 11013767 (Materials and methods for engineering cells and uses thereof in immuno-oncology) held by CRISPR THERAPEUTICS AG expires Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CRISPR THERAPEUTICS AG
- Grant date
- Tue May 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 20 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2239/31, A61K2239/38, A61K2239/48, A61K2239/56